JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Zenocutuzumab is a bispecific humanized monoclonal antibody which targets human Receptor tyrosine-protein kinase erbB-2 (HER2, CD340) and Receptor tyrosine-protein kinase erbB-3 (HER3).